US$ 25.15
cvs glp 1 coverage Impact of GLP-1 formulary change on prescribing GLP-1 Management Strategies
Description
The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Treatments include ...
Take directly into the mouth, or by adding water or juice

GLP-1 SUPER EVOLUTION CAPSULES are formulated to support metabolic wellness and appetite awareness using a plant-based nutritional approach

Interactions with plasma membrane lipids were enhanced by the acyl chain